HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Clinical trials for HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA explained in plain language.
Never miss a new study
Get alerted when new HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA trials appear
Sign up with your email to follow new studies for HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
One-Shot gene therapy aims to permanently lower bad cholesterol
Disease control Recruiting nowThis early-stage study is testing the safety of a single dose of an experimental gene-editing treatment called VERVE-102. It is designed for people with inherited high cholesterol or early heart disease who need to lower their 'bad' LDL cholesterol further. The treatment aims to …
Matched conditions: HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Phase: PHASE1 • Sponsor: Verve Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Spanish doctors track new cholesterol Drug's Real-World impact
Disease control Recruiting nowThis study observes how well the cholesterol-lowering medication Leqvio (inclisiran) works for patients in everyday Spanish medical practice. It follows 200 adults with high cholesterol due to inherited conditions or existing heart disease. Researchers will check if patients reac…
Matched conditions: HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC